The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination
Invasive meningococcal disease (IMD) is a major cause of bacterial meningitis and septicaemia althou...
Invasive meningococcal disease (IMD) is a major cause of bacterial meningitis and septicaemia althou...
Vaccination with meningococcal serogroup C (MenC) conjugate (MCC) polysaccharide vaccines led to a s...
The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased...
Contains fulltext : 196775.pdf (Publisher’s version ) (Open Access)The annual inci...
The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased...
<div><p>Background</p><p>In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (Me...
Background: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was intro...
Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality an...
Background: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was intro...
BACKGROUND: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was intro...
Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality an...
BACKGROUND: Several countries consider the implementation of a meningococcal serogroup B vaccine for...
In 2017, about 760,000 children aged 0 to 19 years received a total of 2,140,000 vaccinations within...
Neisseria meningitidis serogroup B is a major cause of invasive meningococcal disease in Europe. In ...
Invasive meningococcal disease (IMD) is a major cause of bacterial meningitis and septicaemia althou...
Invasive meningococcal disease (IMD) is a major cause of bacterial meningitis and septicaemia althou...
Vaccination with meningococcal serogroup C (MenC) conjugate (MCC) polysaccharide vaccines led to a s...
The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased...
Contains fulltext : 196775.pdf (Publisher’s version ) (Open Access)The annual inci...
The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased...
<div><p>Background</p><p>In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (Me...
Background: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was intro...
Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality an...
Background: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was intro...
BACKGROUND: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was intro...
Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality an...
BACKGROUND: Several countries consider the implementation of a meningococcal serogroup B vaccine for...
In 2017, about 760,000 children aged 0 to 19 years received a total of 2,140,000 vaccinations within...
Neisseria meningitidis serogroup B is a major cause of invasive meningococcal disease in Europe. In ...
Invasive meningococcal disease (IMD) is a major cause of bacterial meningitis and septicaemia althou...
Invasive meningococcal disease (IMD) is a major cause of bacterial meningitis and septicaemia althou...
Vaccination with meningococcal serogroup C (MenC) conjugate (MCC) polysaccharide vaccines led to a s...